Therapeutic Phage Display-Derived Single-Domain Antibodies for Pandemic Preparedness

Driven by necessity, the COVID-19 pandemic caused by SARS-CoV-2 has accelerated the development and implementation of new vaccine platforms and other viral therapeutics. Among these is the therapeutic use of antibodies including single-domain antibodies, in particular the camelid variable heavy-chai...

Descripción completa

Detalles Bibliográficos
Autores principales: Daly, Janet M., Lim, Theam Soon, Gough, Kevin C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887586/
https://www.ncbi.nlm.nih.gov/pubmed/36648891
http://dx.doi.org/10.3390/antib12010007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887586/
https://www.ncbi.nlm.nih.gov/pubmed/36648891
http://dx.doi.org/10.3390/antib12010007

Ejemplares similares